ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
+49.68%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$143M
AUM Growth
+$143M
Cap. Flow
-$19.5M
Cap. Flow %
-13.68%
Top 10 Hldgs %
100%
Holding
15
New
2
Increased
1
Reduced
4
Closed
5

Top Buys

1
RPTX icon
Repare Therapeutics
RPTX
$4.62M
2
KYMR icon
Kymera Therapeutics
KYMR
$2.52M
3
STRO icon
Sutro Biopharma
STRO
$1.8M

Top Sells

1
BPMC
Blueprint Medicines
BPMC
$11.5M
2
SLN
Silence Therapeutics
SLN
$4.67M
3
CCCC icon
C4 Therapeutics
CCCC
$3.7M
4
MRUS icon
Merus
MRUS
$2.06M
5
GMAB icon
Genmab
GMAB
$1.84M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$3.05B
$27.8M 17.33%
908,474
– –
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$23.5M 14.65%
254,827
-124,263
-33% -$11.5M
KYMR icon
3
Kymera Therapeutics
KYMR
$2.95B
$22.4M 13.98%
881,337
+99,118
+13% +$2.52M
ARVN icon
4
Arvinas
ARVN
$568M
$20.1M 12.55%
489,153
– –
SLN
5
Silence Therapeutics
SLN
$227M
$18.1M 11.29%
1,043,284
-268,949
-20% -$4.67M
RGNX icon
6
Regenxbio
RGNX
$451M
$14.4M 8.98%
802,424
-45,000
-5% -$808K
MRUS icon
7
Merus
MRUS
$4.98B
$9.77M 6.09%
355,109
-75,000
-17% -$2.06M
RPTX icon
8
Repare Therapeutics
RPTX
$71.7M
$4.62M 2.88%
+633,271
New +$4.62M
STRO icon
9
Sutro Biopharma
STRO
$72.7M
$1.8M 1.12%
+420,649
New +$1.8M
ARGX icon
10
argenx
ARGX
$43.6B
– –
-3,715
Closed -$1.83M
CCCC icon
11
C4 Therapeutics
CCCC
$185M
– –
-1,990,334
Closed -$3.7M
GMAB icon
12
Genmab
GMAB
$15.3B
– –
-52,148
Closed -$1.84M
OLMA icon
13
Olema Pharmaceuticals
OLMA
$375M
– –
-88,875
Closed -$1.1M
XBI icon
14
SPDR S&P Biotech ETF
XBI
$5.07B
– –
0
– –
PVLA
15
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
– –
-3,303,190
Closed -$984K